Sleep monitoring and diagnostics leader Nox Medical has joined forces with full-service population sleep health company FusionHealth to form Nox Health, becoming one of the world’s largest sleep health leaders.

Nox Medical is pleased to announce its recent hire of 3 new members to its Technical Support Team as well as new U.S. Sales & Training Team. This comes as part of the company ‘s transition from a distributorship sales model…

Nox Medical has appointed Drew Lackner as the company’s VP of Sales and Business Development in the United States. Lackner brings more than 20 years experience in the medical industry with most time spent in the Sleep and Cardiopulmonary Diagnostic space.

Starting today, October 1st 2019, Nox products are sold and supported directly by Nox Medical USA. Distribution relationships for other markets will remain the same. The Nox T3, associated consumables, and support was previously provided by Vyaire Medical in the United…

Nox Medical has appointed Natalie Morin as the company’s new Vice President of Canadian Business Development and Sales.

We would like to inform you that after a 10-year partnership between Vyaire Medical and Nox Medical there will be a change in how our two companies do business. After September 30^th 2019, Vyaire Medical will no longer be the provider of the Nox T3, associated consumables, and support.

Nox Medical has released a new Chain of Custody solution with an innovative Single Body Source analysis in Noxturnal 5.2. This solution is released to meet the increased need for a Chain of Custody solution in some markets.

Nox Medical is proud to announce the successful completion of the Horizon 2020 project funded by EU’s Framework Programme for Research and Innovation.

Nox Medical has won the Icelandic IT Company of the Year Award for outstanding performance in the field of IT . The awards are presented by UTmessan, one of the largest Tech Conference and Expo in Iceland.